Genes in panel
STRs in panel
Prev Next
Regions in panel
Prev Next

Cardiomyopathy_Paediatric

Gene: ETFDH

Amber List (moderate evidence)

ETFDH (electron transfer flavoprotein dehydrogenase, Ensemblv115)
EnsemblGeneIds (GRCh38): ENSG00000171503
EnsemblGeneIds (GRCh37): ENSG00000171503
OMIM: 231675, ClinGen, DECIPHER
ETFDH is in 18 panels

1 review

Zornitza Stark (Victorian Clinical Genetics Services)

I don't know

PMID 30027710 reports two individuals from unrelated families with biallelic ETFDH variants presenting with neonatal‑onset multiple acyl‑CoA dehydrogenase deficiency and biventricular hypertrophy.
Created: 20 Aug 2026, 6:11 p.m. | Last Modified: 20 Aug 2026, 6:11 p.m.
Panel Version: 1.108

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
multiple acyl-CoA dehydrogenase deficiency, MONDO:0009282

Publications

History Filter Activity

Note: This information shows the history of the gene symbol, not the gene entity. Where the gene symbol for a gene has changed, this history may reference a different gene to the entry you are currently viewing.
20 Aug 2026, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: etfdh has been classified as Amber List (Moderate Evidence).

20 Aug 2026, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: ETFDH were changed from Multiple acyl-CoA dehydrogenase deficiency (MADD) (glutaric aciduria type II); Glutaric acidemia IIC; Secondary CoQ10 deficiency (Mitochondrial respiratory chain disorders (caused by nuclear variants only)); HCM; ETF-ubiquinone oxidoreductase deficiency (Disorders of mitochondrial fatty acid oxidation); Facial and cerebral malformations, cystic renal disease, liver disease, hypoketotic hypoglycaemia; Disorders of ubiquinone metabolism and biosynthesis; GLUTARIC ACIDURIA TYPE 2C to multiple acyl-CoA dehydrogenase deficiency, MONDO:0009282

20 Aug 2026, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: ETFDH were set to 24816252; 27604308

20 Aug 2026, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: etfdh has been classified as Amber List (Moderate Evidence).

28 Jul 2020, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

gene: ETFDH was added gene: ETFDH was added to Cardiomyopathy_Paediatric. Sources: NHS GMS,Expert Review Red,MetBioNet Mode of inheritance for gene: ETFDH was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: ETFDH were set to 24816252; 27604308 Phenotypes for gene: ETFDH were set to Multiple acyl-CoA dehydrogenase deficiency (MADD) (glutaric aciduria type II); Glutaric acidemia IIC; Secondary CoQ10 deficiency (Mitochondrial respiratory chain disorders (caused by nuclear variants only)); HCM; ETF-ubiquinone oxidoreductase deficiency (Disorders of mitochondrial fatty acid oxidation); Facial and cerebral malformations, cystic renal disease, liver disease, hypoketotic hypoglycaemia; Disorders of ubiquinone metabolism and biosynthesis; GLUTARIC ACIDURIA TYPE 2C